List of Tables
Table 1. Global Therapeutic Nuclear Medicines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Therapeutic Nuclear Medicines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Therapeutic Nuclear Medicines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Therapeutic Nuclear Medicines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Therapeutic Nuclear Medicines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Therapeutic Nuclear Medicines, Product Types and Applications
Table 12. Global Key Manufacturers of Therapeutic Nuclear Medicines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Nuclear Medicines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Therapeutic Nuclear Medicines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Therapeutic Nuclear Medicines Sales by Region (K Units), 2021–2026
Table 18. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2021–2026)
Table 19. Global Therapeutic Nuclear Medicines Sales by Region (K Units), 2027–2032
Table 20. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2027–2032)
Table 21. Global Therapeutic Nuclear Medicines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2021–2026)
Table 23. Global Therapeutic Nuclear Medicines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2027–2032)
Table 25. North America Therapeutic Nuclear Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Therapeutic Nuclear Medicines Sales by Country (K Units), 2021–2026
Table 27. North America Therapeutic Nuclear Medicines Sales by Country (K Units), 2027–2032
Table 28. North America Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Therapeutic Nuclear Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Therapeutic Nuclear Medicines Sales by Country (K Units), 2021–2026
Table 32. Europe Therapeutic Nuclear Medicines Sales by Country (K Units), 2027–2032
Table 33. Europe Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Therapeutic Nuclear Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Therapeutic Nuclear Medicines Sales by Country (K Units), 2021–2026
Table 42. Latin America Therapeutic Nuclear Medicines Sales by Country (K Units), 2027–2032
Table 43. Latin America Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2021–2026)
Table 51. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2027–2032)
Table 52. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2021–2026)
Table 53. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2027–2032)
Table 54. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2021–2026)
Table 57. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2027–2032)
Table 58. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2021–2026)
Table 59. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2027–2032)
Table 60. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2021–2026)
Table 61. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2027–2032)
Table 62. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2021–2026)
Table 63. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2027–2032)
Table 64. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2021–2026)
Table 67. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2027–2032)
Table 68. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2021–2026)
Table 69. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2027–2032)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Cardinal Health Therapeutic Nuclear Medicines Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. GE Healthcare Therapeutic Nuclear Medicines Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Lantheus Medical Imaging Company Information
Table 81. Lantheus Medical Imaging Description and Business Overview
Table 82. Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Lantheus Medical Imaging Therapeutic Nuclear Medicines Product
Table 84. Lantheus Medical Imaging Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Bayer Therapeutic Nuclear Medicines Product
Table 89. Bayer Recent Developments/Updates
Table 90. Eli Lilly Company Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Eli Lilly Therapeutic Nuclear Medicines Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Bracco Imaging Company Information
Table 96. Bracco Imaging Description and Business Overview
Table 97. Bracco Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Bracco Imaging Therapeutic Nuclear Medicines Product
Table 99. Bracco Imaging Recent Developments/Updates
Table 100. Curium Pharma Company Information
Table 101. Curium Pharma Description and Business Overview
Table 102. Curium Pharma Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Curium Pharma Therapeutic Nuclear Medicines Product
Table 104. Curium Pharma Recent Developments/Updates
Table 105. Jubilant Pharmova Company Information
Table 106. Jubilant Pharmova Description and Business Overview
Table 107. Jubilant Pharmova Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Jubilant Pharmova Therapeutic Nuclear Medicines Product
Table 109. Jubilant Pharmova Recent Developments/Updates
Table 110. Aurobindo Pharma Company Information
Table 111. Aurobindo Pharma Description and Business Overview
Table 112. Aurobindo Pharma Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Aurobindo Pharma Therapeutic Nuclear Medicines Product
Table 114. Aurobindo Pharma Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Novartis Therapeutic Nuclear Medicines Product
Table 119. Novartis Recent Developments/Updates
Table 120. Siemens Company Information
Table 121. Siemens Description and Business Overview
Table 122. Siemens Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Siemens Therapeutic Nuclear Medicines Product
Table 124. Siemens Recent Developments/Updates
Table 125. NTP Radioisotopes Company Information
Table 126. NTP Radioisotopes Description and Business Overview
Table 127. NTP Radioisotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. NTP Radioisotopes Therapeutic Nuclear Medicines Product
Table 129. NTP Radioisotopes Recent Developments/Updates
Table 130. ANSTO Company Information
Table 131. ANSTO Description and Business Overview
Table 132. ANSTO Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. ANSTO Therapeutic Nuclear Medicines Product
Table 134. ANSTO Recent Developments/Updates
Table 135. Polatom Company Information
Table 136. Polatom Description and Business Overview
Table 137. Polatom Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Polatom Therapeutic Nuclear Medicines Product
Table 139. Polatom Recent Developments/Updates
Table 140. China Isotope & Radiation Company Information
Table 141. China Isotope & Radiation Description and Business Overview
Table 142. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. China Isotope & Radiation Therapeutic Nuclear Medicines Product
Table 144. China Isotope & Radiation Recent Developments/Updates
Table 145. Dongcheng Pharma Company Information
Table 146. Dongcheng Pharma Description and Business Overview
Table 147. Dongcheng Pharma Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. Dongcheng Pharma Therapeutic Nuclear Medicines Product
Table 149. Dongcheng Pharma Recent Developments/Updates
Table 150. Saide Bio Company Information
Table 151. Saide Bio Description and Business Overview
Table 152. Saide Bio Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 153. Saide Bio Therapeutic Nuclear Medicines Product
Table 154. Saide Bio Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Therapeutic Nuclear Medicines Distributors List
Table 158. Therapeutic Nuclear Medicines Customers List
Table 159. Therapeutic Nuclear Medicines Market Trends
Table 160. Therapeutic Nuclear Medicines Market Drivers
Table 161. Therapeutic Nuclear Medicines Market Challenges
Table 162. Therapeutic Nuclear Medicines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Therapeutic Nuclear Medicines
Figure 2. Global Therapeutic Nuclear Medicines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type: 2025 & 2032
Figure 4. Radium-223 Product Picture
Figure 5. Lutetium-177 Product Picture
Figure 6. Iodine-131 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Therapeutic Nuclear Medicines Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Therapeutic Nuclear Medicines Market Share by Application: 2025 & 2032
Figure 10. Thyroid
Figure 11. Bone Metastasis
Figure 12. Lymphoma
Figure 13. Other
Figure 14. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Therapeutic Nuclear Medicines Market Size (US$ Million), 2021–2032
Figure 16. Global Therapeutic Nuclear Medicines Sales (K Units), 2021–2032
Figure 17. Global Therapeutic Nuclear Medicines Average Price (USD/Unit), 2021–2032
Figure 18. Therapeutic Nuclear Medicines Report Years Considered
Figure 19. Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2025
Figure 20. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Therapeutic Nuclear Medicines Players: Market Share by Revenue in Therapeutic Nuclear Medicines in 2025
Figure 22. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Therapeutic Nuclear Medicines Sales Market Share by Country (2021–2032)
Figure 25. North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2021–2032)
Figure 26. U.S. Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2021–2032)
Figure 29. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2021–2032)
Figure 30. Germany Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region (2021–2032)
Figure 37. China Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Taiwan Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Therapeutic Nuclear Medicines Sales Market Share by Country (2021–2032)
Figure 48. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Therapeutic Nuclear Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Therapeutic Nuclear Medicines by Type (2021–2032)
Figure 58. Global Revenue Market Share of Therapeutic Nuclear Medicines by Type (2021–2032)
Figure 59. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Therapeutic Nuclear Medicines by Application (2021–2032)
Figure 61. Global Revenue Market Share of Therapeutic Nuclear Medicines by Application (2021–2032)
Figure 62. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2021–2032)
Figure 63. Therapeutic Nuclear Medicines Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
